Professional
Added to YB: 2024-08-22
Pitch date: 2024-07-20
DXCM [bullish]
DexCom, Inc.
-35.91%
current return
Author Info
No bio for this author
Company Info
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.
Market Cap
$27.1B
Pitch Price
$112.76
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.11
P/E
33.71
EV/Sales
5.69
Sector
Health Care Equipment and Supplies
Category
growth
Invesco Health Care Fund Portfolio Holding: DexCom, Inc.
DXCM: Strong growth in CGM devices, new patients, better margins & raised guidance. Sentiment down on inventory destocking, health plan switching & vendor cyberattack disrupting Medicaid claims. Wearable glucose monitors for diabetes treatment.
Read full article (1 min)